UK secures 60 million doses of new Novavax vaccine with 89% efficacy against coronavirus
An experimental Covid-19 vaccine appears to offer strong protection in late-stage UK and South Africa studies, said manufacturer Novavax. The UK has secured access to 60 million doses of the
Read More